NASDAQ · Medical - Distribution
RDGT (RDGT) Stock
$1.23
-1.60%
NASDAQ: RDGT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association
PR Newswire · Jul 24, 2026
Top Premarket Gainers
MT Newswires · Jul 21, 2026
BC-Most Active Stocks
Associated Press · Jun 23, 2026
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
Benzinga · May 13, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.41%
Institutions Held0.02%
Institutions Float Held0.02%
Peer Comparison
About RDGT
RDGT is led by CEO Ming Zhao, employs 939 people, headquartered in CN, publicly traded since 2024.
RDGT stock trades at $1.23 with a market capitalization of $1.11M. The stock is valued at a price-to-earnings (P/E) ratio of 0.16, price-to-book of 0.21, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.21 and $760.50, and currently trades 99.8% below its 52-week high.
On profitability, RDGT generates a return on equity (ROE) of 41.78% — well above the market average, a sign of a high-quality business, return on capital employed of -3.45%, an operating margin of -0.83%, a net profit margin of 11.12%.